GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Accounts Payable & Accrued Expense

Basilea Pharmaceutica (XSWX:BSLN) Accounts Payable & Accrued Expense : CHF11.5 Mil (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Accounts Payable & Accrued Expense?

Basilea Pharmaceutica's quarterly accounts payable & accrued expense increased from Jun. 2023 (CHF4.4 Mil) to Dec. 2023 (CHF5.8 Mil) and increased from Dec. 2023 (CHF5.8 Mil) to Jun. 2024 (CHF11.5 Mil).

Basilea Pharmaceutica's annual accounts payable & accrued expense declined from Dec. 2021 (CHF12.1 Mil) to Dec. 2022 (CHF0.2 Mil) but then increased from Dec. 2022 (CHF0.2 Mil) to Dec. 2023 (CHF5.8 Mil).

Basilea Pharmaceutica Accounts Payable & Accrued Expense Historical Data

The historical data trend for Basilea Pharmaceutica's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Accounts Payable & Accrued Expense Chart

Basilea Pharmaceutica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.37 14.75 12.12 0.19 5.85

Basilea Pharmaceutica Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.31 0.19 4.44 5.85 11.47

Basilea Pharmaceutica Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Basilea Pharmaceutica Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
XSWX:IDIA XSWX:MOLN XSWX:NWRN XSWX:XLS XSWX:SANN XSWX:RLF XSWX:ADXN VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR
Traded in Other Exchanges
BPMUF:USA BSLNz:UK 0QNA:UK
Address
Hegenheimermattweg 167b, Allschwil, CHE, 4123
Website
https://www.basilea.com
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica Headlines

No Headlines